enVVeno Medical Corp Cash and Cash Equivalents, Period Increase (Decrease)
enVVeno Medical Corp (NVNO) reported Cash and Cash Equivalents, Period Increase (Decrease) of $821.92 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-05-09
- enVVeno Medical Corp cash and cash equivalents, period increase (decrease) for the quarter ending 2019-03-31 was $821.92K, a 255.13% increase year-over-year.
- enVVeno Medical Corp cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$1.45M.
- enVVeno Medical Corp cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was $231.44K.
- enVVeno Medical Corp cash and cash equivalents, period increase (decrease) for the quarter ending 2017-12-31 was -$233.79K.
- enVVeno Medical Corp cash and cash equivalents, period increase (decrease) for fiscal 2018 was $2.66M, a 12476.54% increase from fiscal 2017.
- enVVeno Medical Corp cash and cash equivalents, period increase (decrease) for fiscal 2017 was $21.17K.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2019-03-31 | $821.92K 10-Q · filed 2019-05-09 | -$626.88K derived: sum of 2 quarters · filed 2019-05-09 | ||
| 2018-12-31 | -$1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $2.66M 10-K · filed 2019-03-14 | ||
| 2018-09-30 | $4.11M 10-Q · filed 2018-11-07 | |||
| 2018-03-31 | $231.44K 10-Q · filed 2019-05-09 | -$2.35K derived: sum of 2 quarters · filed 2019-05-09 | ||
| 2017-12-31 | -$233.79K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $21.17K 10-K · filed 2019-03-14 | ||
| 2017-09-30 | $254.97K 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |